InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Klichinsky Michael, Chief Scientific Officer. Officer active across 1 company, notably Carisma Therapeutics Inc.. Aggregated, 3 disclosures have been logged. Breakdown: 0 buy · 1 sell. Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Klichinsky Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
56,982 shares@ €0.0944Common StockSEC:0001104659-25-097928:0
165,000 shares@ €0.21950.0% of flowCommon StockSEC:0001104659-25-096740:0
484,347 sharesCommon StockSEC:0001104659-23-030750:0
3 of 3 declarations
About Klichinsky Michael
Michael Klichinsky is the Chief Scientific Officer at Carisma Therapeutics Inc. He is responsible for overseeing the company's scientific and research initiatives, focusing on the development of new therapies. His expertise in biology and clinical research is essential for Carisma's innovation.
